Business services, nec, nec, Commercial research laboratory
Tissue Gene
Kolon TissueGene, based in Rockville, MD, is a biopharmaceutical company focused on developing advanced cell therapies aimed at treating orthopedic diseases and degenerative disorders, with a notable emphasis on osteoarthritis of the knee. Their key product, TG-C, is designed to alleviate pain, enhance function, and slow disease progression through allogeneic cell and gene therapy.
With a commitment to addressing unmet medical needs, Kolon TissueGene leverages innovative technology to advance clinical-stage therapies. The company aims to reshape treatment approaches within the orthopedic field through its state-of-the-art research and development initiatives. Generated from the website